The most useful longevity blood test is usually not exotic. In practice, ApoB, HbA1c, fasting insulin, hs-CRP, cystatin C, ALT, GGT, ferritin, and 25-hydroxy vitamin D give the clearest signal about arterial aging, metabolic stress, kidney reserve, liver health, iron balance, and frailty risk.
- ApoB below 90 mg/dL is a reasonable primary-prevention target, while values at or above 130 mg/dL are clearly high.
- HbA1c under 5.7% is normal, 5.7% to 6.4% indicates prediabetes, and 6.5% or higher supports diabetes when confirmed.
- Fasting insulin under about 8 µIU/mL is generally favorable; persistent values above 10 to 12 µIU/mL often suggest early insulin resistance.
- hs-CRP under 1.0 mg/L suggests low inflammatory burden, while values above 3.0 mg/L raise concern if they persist.
- Cystatin C around 0.61 to 0.95 mg/L is typical in many adults; a cystatin C-based eGFR under 60 mL/min/1.73m² for 3 months supports CKD.
- ALT above roughly 25 U/L in women or 33 U/L in men deserves context even if the printed lab range is wider.
- GGT above 40 to 60 U/L is commonly abnormal, but metabolic risk can show up earlier, sometimes above 30 U/L.
- Ferritin below 30 ng/mL often means depleted iron stores; ferritin above 300 ng/mL in men or above 200 ng/mL in many women needs interpretation with transferrin saturation and CRP.
- 25-hydroxy vitamin D below 20 ng/mL is deficient, 30 to 50 ng/mL is a practical target for most adults, and levels above 100 ng/mL can be toxic.
What a longevity blood test should actually measure
A useful longevity blood test is not a mystery panel. As of April 14, 2026, the 9 markers I trust most in routine practice are ApoB, HbA1c, fasting insulin, hs-CRP, cystatin C, ALT, GGT, ferritin, and 25-hydroxy vitamin D; together they tell us far more than most boutique wellness panels, and they can be interpreted quickly on Kantesti AI or compared with a formal biological age blood test workflow.
A real longevity panel looks for the biology that ages people fastest: atherosclerosis, insulin resistance, chronic low-grade inflammation, silent kidney decline, fatty liver, and nutrient imbalance. In my clinic, Thomas Klein, MD, I usually start there before I touch any expensive biohacking blood test.
The thing most readers miss is that reference range does not equal optimal range. A result can be technically normal and still sit in the part of the curve where we see more metabolic trouble over time, which is why Kantesti AI interprets results against lab-specific ranges, age, sex, medications, and pattern recognition rather than a green-or-red shortcut.
In our review of millions of uploaded reports, the most informative signal is often a cluster, not a lone number. ApoB drifting up, fasting insulin creeping into double digits, and GGT nudging higher together usually tell me more than a flashy one-off wellness blood test claiming to measure biological destiny.
Most patients do better with repeatable basics than with novelty. A preventive blood test should change something practical within 24 hours: diet, alcohol intake, training load, sleep timing, a medication discussion, or the decision to order a follow-up test.
Why I de-prioritize some popular longevity add-ons
Single-result age clocks, isolated cortisol readings, and broad micronutrient megapanels often create noise before they create action. If your budget is limited, spend it on the core nine first, then add second-line markers only when history, symptoms, or family risk gives them a job to do.
ApoB is the blood marker we trust most for arterial aging
ApoB is the best routine blood marker for atherosclerotic particle burden. In most adults, a level below 90 mg/dL is a reasonable primary-prevention goal, below 80 mg/dL is better for many higher-risk patients, and 130 mg/dL or higher is clearly high; if you still think only in LDL, start with our LDL risk cutoff guide.
ApoB matters because each atherogenic lipoprotein particle carries one ApoB molecule. That means ApoB is a particle count, not just a cholesterol content estimate, and particle count is what drives traffic into the artery wall.
I see this pattern all the time: LDL-C looks decent, but ApoB is still elevated because the patient has insulin resistance, high triglycerides, central weight gain, or a strong family history. A 46-year-old with LDL-C 112 mg/dL and ApoB 124 mg/dL is not low risk just because the older lipid marker looks less dramatic.
Statin-treated patients are another group where ApoB helps. When LDL-C and ApoB disagree, I trust ApoB more, especially if triglycerides are above 150 mg/dL, HDL is low, or waist circumference is climbing.
ApoB does not require fasting in most cases. The practical tip is consistency: use the same lab when possible, and judge progress over 8 to 12 weeks after a treatment or lifestyle change rather than from one anxious retest.
When LDL and ApoB disagree
Discordance is common in metabolic syndrome and early type 2 diabetes. If LDL-C is near goal but ApoB stays high, the patient still has too many artery-penetrating particles, and that is the number I act on.
HbA1c captures chronic glucose exposure better than a single fasting sugar
HbA1c reflects average glucose exposure over roughly 8 to 12 weeks. In adults, below 5.7% is normal, 5.7% to 6.4% indicates prediabetes, and 6.5% or higher supports diabetes when confirmed; see our detailed HbA1c cutoff guide.
HbA1c is useful because it is not easily fooled by one stressful morning or one perfect fast. The last 30 days contribute more heavily than the earlier part of the 3-month window, so a recent dietary change can move the number sooner than patients expect.
Here is where context matters more than the internet usually admits: iron deficiency can falsely raise HbA1c, while hemolysis, recent blood loss, or shortened red-cell survival can falsely lower it. When I see an HbA1c of 5.9% in a fatigued patient with microcytosis, I check the CBC and iron story before I label that person prediabetic.
A single fasting glucose can still help. If HbA1c is 5.4% but fasting glucose is repeatedly 102 to 108 mg/dL, or if morning sugars stay odd, I cross-check with our fasting glucose guide and look for sleep apnea, late eating, or medication effects.
Most longevity-focused patients do not need HbA1c at the bottom of the range at any cost. In practice, the sweet spot is stability: a safe number, no big swings, and no drift upward year by year.
Why athletes and anemic patients can misread HbA1c
Red-cell lifespan changes the test. Endurance training, hemoglobin variants, chronic kidney disease, and iron deficiency can all distort HbA1c enough to mislead a very health-conscious person who otherwise seems low risk.
Fasting insulin often moves years before glucose does
Fasting insulin is one of the earliest practical aging markers we use. In my experience, values around 2 to 7 µIU/mL are often favorable, persistent results above 10 to 12 µIU/mL suggest insulin resistance, and a HOMA-IR above 2.0 deserves attention; our HOMA-IR explainer walks through the math.
Many labs print a fasting insulin upper limit around 20 to 25 µIU/mL, but that range is a disease-detection range, not an optimal-aging range. A fasting insulin of 14 µIU/mL with glucose 92 mg/dL is the sort of quiet metabolic signal I would not ignore.
This is where patients get tripped up by a wellness blood test result marked normal in green. If insulin is climbing while weight, triglycerides, sleep quality, or waist circumference are also moving the wrong way, the physiology is already changing even before HbA1c crosses the prediabetes line.
I rarely read fasting insulin alone. When insulin is high and fasting triglycerides are also rising, the pattern is more convincing, so it helps to check our triglyceride range guide.
One caveat: a low fasting insulin is not automatically good. If insulin is very low while glucose is high, we worry less about resistance and more about inadequate insulin secretion, weight loss, or a different diabetes phenotype.
When fasting insulin is most useful
It is especially good at spotting trouble in the patient who still looks fine on a basic chemistry panel. A 38-year-old with normal HbA1c, borderline triglycerides, mild fatty liver, and fasting insulin of 16 µIU/mL is already giving us a prevention window.
hs-CRP is crude, but it still tracks inflammaging surprisingly well
hs-CRP is a blunt marker, but it remains clinically useful. A value below 1.0 mg/L suggests low background inflammation, 1.0 to 3.0 mg/L is intermediate, above 3.0 mg/L is elevated, and above 10 mg/L usually points to an acute trigger rather than steady aging biology; use our CRP range guide for context.
CRP is made in the liver, largely under IL-6 signaling, and it can change fast. That is why one bad night, a dental infection, a recent vaccine, hard training, or even a mild viral illness can distort the result for days.
Persistently elevated hs-CRP still matters. In routine prevention, a person sitting at 2.5 to 3.5 mg/L for months often has a modifiable driver such as visceral adiposity, periodontal disease, sleep apnea, smoking exposure, or untreated inflammatory skin disease.
I rarely panic over a single result unless it is extreme. Most patients do better with a repeat test 2 to 4 weeks after they are fully well, because a stable CRP trend is far more informative than an isolated spike.
The subtle point is this: hs-CRP does not tell you where the inflammation is. It tells you the body thinks something is worth reacting to, and that is enough to justify looking harder.
Why I do not use hs-CRP alone
A normal hs-CRP does not guarantee low risk, and a high one does not diagnose a disease. I read it beside ApoB, ferritin, CBC patterns, symptoms, and the time course of the result.
Cystatin C can reveal kidney aging earlier than creatinine
Cystatin C is often a better aging marker than creatinine because it is less dependent on muscle mass. Adult values around 0.61 to 0.95 mg/L are common, while a cystatin C-based eGFR below 60 mL/min/1.73m² for at least 3 months supports chronic kidney disease; see our GFR vs eGFR guide.
Creatinine is useful, but it can be misleading in two opposite directions. A muscular 32-year-old taking creatine may look worse than he is, while a frail 79-year-old with low muscle mass may look better than she is.
Cystatin C reduces that bias, though it is not flawless. Smoking, thyroid dysfunction, corticosteroids, and some inflammatory states can shift cystatin C enough that I still compare it with the usual creatinine interpretation.
The combined creatinine-cystatin C equation is often the most clinically useful estimate. When both markers point in the same direction, my confidence goes up; when they diverge, I start asking about muscle mass, supplements, thyroid status, and medication exposure.
Kidney reserve is a genuine longevity issue because it changes cardiovascular risk, blood pressure behavior, drug handling, and resilience during illness. A tiny decline each year can stay invisible for a long time if nobody is looking.
When creatinine looks normal but risk is not
I see this in older adults more than the internet suggests. A creatinine of 0.7 mg/dL can look reassuring until cystatin C and clinical context reveal that the kidney reserve is thinner than the basic panel implies.
ALT and GGT together flag liver and metabolic aging
ALT and GGT are two of the most underappreciated longevity labs. ALT above about 25 U/L in women or 33 U/L in men deserves context even when the printed range is wider, and GGT above 40 to 60 U/L is commonly abnormal, though metabolic risk often appears earlier; start with our liver enzyme reading guide.
ALT is mainly a hepatocellular stress marker, while GGT is more sensitive to bile-duct signaling, alcohol exposure, oxidative stress, and metabolic dysfunction. In practice, GGT often rises before ALT in patients drifting toward fatty liver.
A 52-year-old marathon runner with AST 89 U/L after a race does not scare me much if ALT is 32 U/L, CK is high, and the story fits muscle release. A sedentary patient with ALT 41 U/L, GGT 58 U/L, triglycerides 220 mg/dL, and fasting insulin 15 µIU/mL is a very different conversation.
The ratio and pattern matter. If you want that deeper nuance, our AST/ALT ratio guide is useful, and isolated GGT elevations deserve their own review in our high GGT article.
Before repeating liver enzymes, I usually ask patients to avoid hard training for 48 hours and alcohol for 72 hours. That one step alone prevents a surprising number of false alarms.
Why printed lab normals can be too generous
Some reference ranges were built from populations with a lot of unrecognized fatty liver. That means a result can be called normal by the lab while still being unhelpfully high for long-term metabolic health.
25-hydroxy vitamin D matters, but more is not better
25-hydroxy vitamin D is the correct blood test for vitamin D status. A level below 20 ng/mL is deficient, 20 to 29 ng/mL is often called insufficient, 30 to 50 ng/mL is a practical target for most adults, and above 100 ng/mL can be toxic; our vitamin D chart goes deeper.
The evidence here is honestly mixed. Vitamin D deficiency clearly matters for bone and muscle health, and probably for frailty risk, but megadosing vitamin D has not turned into a simple lifespan hack.
This marker is highly contextual. Obesity, darker skin in low-sun climates, malabsorption, chronic kidney disease, certain anticonvulsants, and a mostly indoor routine can all push 25-OH vitamin D down even in people who feel generally well.
International units trip people up. 30 ng/mL equals about 75 nmol/L, which is why some European lab reports look very different at first glance even when they are clinically saying the same thing.
Too much is not better. Once I see vitamin D over 80 to 100 ng/mL, especially with high calcium, I start asking about dose stacking, fortified powders, and whether the patient is taking more because the internet told them higher always means healthier.
How soon vitamin D changes after supplementation
In most adults, retesting after 8 to 12 weeks is reasonable. Testing again after 10 days usually just buys confusion.
Which advanced longevity labs help — and which are mostly expensive noise?
The most useful add-on markers are the ones that change management. After the core nine, I most often consider Lp(a), TSH with free T4, vitamin B12, uric acid, or selected hormone testing, while many fancy biohacking panels stay low on my list; if you want the full menu, our 15,000+ biomarker guide shows what each test is actually for.
A one-time Lp(a) level is often worthwhile because it is genetically determined and helps explain apparently premature vascular disease. Thyroid testing is useful when lipids are odd, fatigue is prominent, constipation or palpitations show up, or the history hints at autoimmune disease.
Hormone testing is where context gets lost fastest. In women, cycle timing and perimenopause timing matter a lot, which is why I often send patients to our women's hormone guide before they spend money on a random Sunday-morning hormone panel.
Our clinicians on the Medical Advisory Board tend to ask one simple question before ordering an advanced marker: what will we do differently if the result is high, low, or normal? If the honest answer is nothing, the test can wait.
What I usually de-prioritize: isolated cortisol, broad food sensitivity IgG, unspecific oxidative-stress bundles, and costly age scores that do not map to a validated treatment pathway. Most patients feel disappointed hearing that, but it saves them time, money, and the wrong kind of worry.
Useful add-ons only after the core panel is stable
Advanced testing works best when the basics are already controlled. There is no point in obsessing over a borderline homocysteine while ApoB is 138 mg/dL, fasting insulin is 17 µIU/mL, and GGT is climbing.
How to use a preventive blood test without chasing every fluctuation
For most adults, repeating a preventive blood test every 6 to 12 months is enough. Retest earlier, usually after 8 to 12 weeks, if you changed medication, lost or gained at least 5% body weight, started supplements, or are following an abnormal result; you can try that workflow on our free demo at Try Free AI Blood Test Analysis.
Consistency beats perfection. If insulin and triglycerides are part of your panel, an 8 to 12 hour fast is sensible, and our fasting guide covers the details; ApoB itself usually does not require fasting, but using similar conditions helps trend quality.
Pre-analytic noise is real. I tell patients to skip very hard exercise for 24 to 48 hours, avoid alcohol for 72 hours if liver markers matter, and mention supplements because biotin, creatine, and even aggressive hydration habits can confuse interpretation.
Kantesti AI can read PDFs or photos in about a minute, compare new results with prior panels, and surface family-risk context from the same report. If you are uploading older and newer labs together, our PDF upload guide helps you prepare clean files, and our AI-powered blood test interpretation engine explains why the change matters rather than just flagging color boxes.
When I, Thomas Klein, MD, review a serial panel, I care about direction and clustering more than one-off outliers. Kantesti's clinical framework is outlined on our medical validation page, and the same rule holds in human practice: do not change your life based on a single mildly abnormal number without context.
When to seek care sooner
Do not wait for trend analysis if you have chest pain, progressive shortness of breath, jaundice, black stools, fainting, severe weakness, or rapid unexplained weight loss. A longevity blood test is for prevention, not for triaging emergencies.
Research publications and methodology
These two references are the ones we currently surface most often when readers want source transparency around editorial standards and hormone-pattern context. If you want to see the wider company background behind our review process, the best starting point is About Us.
Mitchell, S., & Klein, T. (2026). Women's Health Guide: Ovulation, Menopause & Hormonal Symptoms. Figshare. https://doi.org/10.6084/m9.figshare.31830721. ResearchGate. Academia.edu.
Klein, T., & Mitchell, S. (2026). Clinical Validation Framework v2.0. Zenodo. https://doi.org/10.5281/zenodo.17993721. ResearchGate. Academia.edu.
Neither reference is a shortcut to clinical certainty, and that is the point. Good longevity medicine still depends on repeated measurements, symptoms, medications, family history, and what changes after you intervene.
Frequently Asked Questions
What is the best longevity blood test to get first?
The best first longevity blood test is usually a focused panel built around ApoB, HbA1c, fasting insulin, hs-CRP, cystatin C, ALT, GGT, ferritin, and 25-hydroxy vitamin D. Those 9 markers cover arterial risk, glucose control, insulin resistance, inflammation, kidney reserve, liver stress, iron balance, and deficiency risk better than most exotic panels. In practice, I would choose these before telomere tests or expensive age scores because they are actionable within days, not just interesting.
How often should you repeat a longevity blood test?
Most healthy adults only need a longevity blood test every 6 to 12 months. Retesting sooner, usually after 8 to 12 weeks, makes sense after a medication change, a new supplement routine, a significant weight shift of about 5% or more, or a clearly abnormal result that you are trying to improve. Monthly testing is usually too noisy unless there is a specific medical reason.
Do you need to fast before a longevity blood test?
Fasting is most useful when fasting insulin, triglycerides, or fasting glucose are part of the panel. An 8 to 12 hour fast is standard for those markers, while ApoB itself can usually be measured accurately without fasting. Water is fine, but hard exercise for 24 to 48 hours and alcohol for 72 hours can distort liver enzymes and should be avoided if you want cleaner trend data.
Are advanced biohacking blood tests worth it?
Advanced biohacking blood tests can help, but only after the core routine markers are under control. I find that one-time Lp(a), targeted thyroid testing, vitamin B12 in higher-risk groups, or uric acid in metabolic patients are often more useful than broad cortisol bundles or proprietary age scores. If a test result will not change treatment, diet, medication, or follow-up, it is usually low value.
Can one abnormal biomarker predict how long you will live?
No single biomarker can reliably predict lifespan on its own. A mildly high ApoB, ferritin, GGT, or hs-CRP often matters more when it travels with other abnormalities and when it stays abnormal over time. In clinical practice, clusters and trends are what make a longevity blood test predictive enough to guide prevention.
At what age should preventive blood testing for longevity start?
For most adults, a baseline preventive blood test in the late 20s to mid-30s is reasonable, and earlier testing makes sense with obesity, hypertension, PCOS, family history of early cardiovascular disease, or prediabetes. The goal is not to medicalize youth; it is to capture a personal baseline before the usual age-related drift begins. Once you have that baseline, repeating the panel every 1 to 2 years in lower-risk adults is often enough.
Can Kantesti read my longevity blood test from a PDF or photo?
Yes. Kantesti AI can interpret a lab PDF or photo in about 60 seconds, compare current and past results, and explain how biomarkers such as ApoB, HbA1c, fasting insulin, ferritin, and vitamin D fit together. That is particularly useful when a result is technically normal but trending in the wrong direction over 6 to 12 months.
Get AI-Powered Blood Test Analysis Today
Join over 2 million users worldwide who trust Kantesti for instant, accurate lab test analysis. Upload your blood test results and receive comprehensive interpretation of 15,000+ biomarkers in seconds.
📚 Referenced Research Publications
Klein, T., Mitchell, S., & Weber, H. (2026). Women's Health Guide: Ovulation, Menopause & Hormonal Symptoms. Kantesti AI Medical Research.
Klein, T., Mitchell, S., & Weber, H. (2026). Clinical Validation Framework v2.0 (Medical Validation Page). Kantesti AI Medical Research.
⚕️ Medical Disclaimer
This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for diagnosis and treatment decisions.
E-E-A-T Trust Signals
Experience
Physician-led clinical review of lab interpretation workflows.
Expertise
Laboratory medicine focus on how biomarkers behave in clinical context.
Authoritativeness
Written by Dr. Thomas Klein with review by Dr. Sarah Mitchell and Prof. Dr. Hans Weber.
Trustworthiness
Evidence-based interpretation with clear follow-up pathways to reduce alarm.